montelukast 4 MG Chewable Tablet
montelukast
RxCUI: 311759
What the CMS Formulary Data Shows for montelukast 4 MG Chewable Tablet
Per the CMS 2026 Part D formulary file, montelukast 4 MG Chewable Tablet (RxNorm concept RXCUI 311759, generic name montelukast) appears on 329 distinct formulary files spanning 5,066 Medicare Part D plan offerings - 100% of enrollable Part D products, near-universal placement. Tier placement ranges from Tier 1 to Tier 4, with a cross-plan average of Tier 1.6.
Real-world access to montelukast 4 MG Chewable Tablet depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 0% require step therapy. 16.7% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 3,063,882 Part D beneficiaries filled montelukast 4 MG Chewable Tablet in 2023, with total plan-and-beneficiary spending of $190,742,362 and an average per-beneficiary annual cost of $62.26. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry montelukast 4 MG Chewable Tablet today.
Coverage Details
- Formularies covering
- 329
- Plans covering
- 5,066
- Coverage rate
- 100%
- Tier range
- Tier 1 – Tier 4
- Average tier
- Tier 2, Generic
Restrictions
- Prior authorization required
- 0% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 16.7% of formularies
2023 Medicare Spending
- Beneficiaries
- 3,063,882
- Total spending
- $190,742,362
- Avg per beneficiary
- $62.26
Tier Distribution Across Plans
Standalone Drug Plans (PDP) Covering montelukast 4 MG Chewable Tablet
2 standalone prescription drug plans include this drug.
| Plan | Insurer | Tier | PA | ST | Premium | States |
|---|---|---|---|---|---|---|
| AARP Medicare Rx Preferred from UHC (PDP) | UNITEDHEALTHCARE INS. CO. & UHC INS. CO. OF NY | T1 | No | No | $0 | - |
| AARP Medicare Rx Preferred from UHC (PDP) | UNITEDHEALTHCARE INS. CO. & UHC INS. CO. OF NY | T1 | No | No | $0 | - |
Medicare Advantage Plans (MA-PD) Covering montelukast 4 MG Chewable Tablet
98 Medicare Advantage plans with Part D drug coverage include this drug.
Frequently Asked Questions
Is montelukast 4 MG Chewable Tablet covered by Medicare Part D?
Yes, montelukast 4 MG Chewable Tablet is covered by 5,066 Medicare Part D plans (100% of all Part D formularies).
What tier is montelukast 4 MG Chewable Tablet on Medicare Part D plans?
montelukast 4 MG Chewable Tablet averages Tier 1.6 across Part D plans, ranging from Tier 1 to Tier 4.
Does montelukast 4 MG Chewable Tablet require prior authorization?
0% of Part D formularies require prior authorization for montelukast 4 MG Chewable Tablet. Step therapy: 0%. Quantity limits: 16.7%.
How much does Medicare spend on montelukast 4 MG Chewable Tablet?
In 2023, total Medicare Part D spending on montelukast 4 MG Chewable Tablet was $190,742,362, covering 3,063,882 beneficiaries. The average spend per beneficiary was $62.26.
Read our methodology - how this data is sourced, computed, and verified.